Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021.

African lion COVID-19 Indiana One Health RT-PCR SARS-CoV-2 United States biosecurity coronavirus disease rapid test respiratory infections risk factor severe acute respiratory syndrome coronavirus 2 vaccine-preventable diseases viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
06 2023
Historique:
medline: 22 5 2023
pubmed: 19 4 2023
entrez: 18 4 2023
Statut: ppublish

Résumé

We describe animal-to-human transmission of SARS-CoV-2 in a zoo setting in Indiana, USA. A vaccinated African lion with physical limitations requiring hand feeding tested positive for SARS-CoV-2 after onset of respiratory signs. Zoo employees were screened, monitored prospectively for onset of symptoms, then rescreened as indicated; results were confirmed by using reverse transcription PCR and whole-genome virus sequencing when possible. Traceback investigation narrowed the source of infection to 1 of 6 persons. Three exposed employees subsequently had onset of symptoms, 2 with viral genomes identical to the lion's. Forward contact tracing investigation confirmed probable lion-to-human transmission. Close contact with large cats is a risk factor for bidirectional zoonotic SARS-CoV-2 transmission that should be considered when occupational health and biosecurity practices at zoos are designed and implemented. SARS-CoV-2 rapid testing and detection methods for big cats and other susceptible animals should be developed and validated to enable timely implementation of One Health investigations.

Identifiants

pubmed: 37069611
doi: 10.3201/eid2906.230150
pmc: PMC10202875
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1102-1108

Références

Emerg Infect Dis. 2021 Apr;27(4):1015-1022
pubmed: 33770472
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
Emerg Infect Dis. 2021 Feb;27(2):547-551
pubmed: 33207152
J Zoo Wildl Med. 2021 Dec;52(4):1224-1228
pubmed: 34998292
mBio. 2020 Oct 13;11(5):
pubmed: 33051368
Emerg Infect Dis. 2022 Jul;28(7):1485-1488
pubmed: 35666777
Emerg Infect Dis. 2022 Apr;28(4):833-836
pubmed: 35318922
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Int J Infect Dis. 2022 Sep;122:295-299
pubmed: 35643308
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Clin Microbiol Infect. 2022 Mar;28(3):451.e1-451.e4
pubmed: 34920116
Lancet. 2022 Mar 12;399(10329):1070-1078
pubmed: 35279259
Emerg Infect Dis. 2021 Dec;27(12):3171-3173
pubmed: 34808082
Transbound Emerg Dis. 2022 Sep;69(5):e3060-e3075
pubmed: 35839756
Zoonoses Public Health. 2022 Aug;69(5):587-592
pubmed: 35426241
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35078920
Viruses. 2022 Jan 11;14(1):
pubmed: 35062324

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH